How Our Bodies Fight Against cancer? Why Patients Often Relapse Following Treatment?
Every day, we have to see new and better advancements in medical science. In the recent past, there has been rising number of cancer cases due to various reasons.
In a recent study conducted and published in the Journal of Clinical Investigation, it can help develop new approaches towards treating people with diseases like leukaemia - blood cancer.
As per a recent research conducted by researchers, our body's immune system are designed in such a way that they can trigger an attack on them.
As per the new findings done in this regard, there
can be some new approaches implemented to treat some dreaded disorders like
leukaemia - blood cancer.
The research was conducted by a team
of researchers from the University of East Anglia (UEA), they found that
certain immune cells named macrophages can be programmed in such a way that
they can attack cancer cells through a related protein called STING (Stimulator
of interferon genes).
This protein happens to be a well
established activator of the immune system that can attack any such invaders of
our immune system.
This is what the researchers have to
say, "Our results provide insight into how the immune system is able to be
utilized to attack cancers if given the right signals," they said.
"Patients often relapse
following treatment for cancer, because small amounts of disease remain despite
chemotherapy. Our research reveals that targeting this biological phenomenon
could help eradicate leukaemia from the bone marrow," he added.
How Our Bodies Fight Against cancer? Why Patients Often Relapse Following Treatment?
In the original study conducted, the
researchers clearly identified the above mechanisms in the bone marrow of
leukaemia patients along with some of the mouse models of acute myeloid
leukaemia. However, if you see in the west, there are rising number of asbestos exposure cases due to which cancer cases are on the rise.
"At present, sadly chemotherapy is often not enough to cure people of leukaemia. In the future, I hope our findings will help improve treatments for people with leukaemia by priming their immune response to help the chemotherapy drugs work better," this is what one of the researchers said.
Also Read: Cancer cases Rising Among Adolescents & Young Adults, ICMR Study
Comments
Post a Comment